Spinal cord glia (microglia and astrocytes) contribute to enhanced pain states. One model that has been used to study this phenomenon is intrathecal (i.t.) administration of gp120, an envelope glycoprotein of HIV-1 known to activate spinal cord glia and thereby induce low-threshold mechanical allodynia, a pain symptom where normally innocuous (non-painful) stimuli are perceived as painful. Previous studies have shown that i.t. gp120-induced allodynia is mediated via the release of the glial pro-inXammatory cytokines, tumor necrosis factor-(TNF), and interleukin-1 (IL-1). As we have recently reported that i.t. gp120 induces the release of interleukin-6 (IL-6), in addition to IL-1 and TNF, the present study tested whether this IL-6 release in spinal cord contributes to gp120-induced mechanical allodynia and/or to gp120-induced increases in TNF and IL-1. An i.t. anti-rat IL-6 neutralizing antibody was used to block IL-6 actions upon its release by i.t. gp120. This IL-6 blockade abolished gp120-induced mechanical allodynia. While the literature predominantly documents the cascade of pro-inXammatory cytokines as beginning with TNF, followed by the stimulation of IL-1, and Wnally TNF plus IL-1 stimulating the release of IL-6, the present Wndings indicate that a blockade of IL-6 inhibits the gp120-induced elevations of TNF, IL-1, and IL-6 mRNA in dorsal spinal cord, elevation of IL-1 protein in lumbar dorsal spinal cord, and TNF and IL-1 protein release into the surrounding lumbosacral cerebrospinal Xuid. These results would suggest that IL-6 induces pain facilitation, and may do so in part by stimulating the production and release of other pro-inXammatory cytokines.
Interleukin-6 mediates low-threshold mechanical allodynia induced by intrathecal HIV-1 envelope glycoprotein gp120 
Introduction
Pain enhancement has classically been thought to result from the sensitization of dorsal horn spinal cord neurons by neuronally-derived substances such as substance P, glutamate, and nitric oxide (NO) (Haley et al., 1992) . However, in recent years, it has become clear that spinal cord glia can be intimately involved in the creation and maintenance of diverse enhanced pain states (DeLeo and Yezierski, 2001; Watkins and Maier, 2003) .
Although the involvement of glia in pain facilitation is now widely accepted, how exactly glia contribute to enhanced pain states is not fully understood. Upon activation, glia have been shown to release the pro-inXammatory cytokines, tumor necrosis factor-(TNF), interleukin-1 (IL-1), and interleukin-6 (IL-6). Currently the clearest evidence for pro-inXammatory cytokine involvement in pain enhancement comes from studies of TNF and IL-1 in spinal cord. Spinal TNF and IL-1 mRNA expression, protein production, and release are increased in response to various pain enhancing manipulations (DeLeo and Colburn, 1999; Milligan et al., 2001 Milligan et al., , 2003 . Both intrathecal (i.t.) TNF and i.t. IL-1 have been reported to elicit pain behaviors (Kwon et al., 2005) and enhance neuronal
